NCT06163521 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Alnahdi GH, Schwab S, Elahdi A, Alnahdi AH
The Positive Impact of Joint Activities on Students Attitudes Toward Peers With Disabilities. Front Psychol. 2021 Sep 8;12:690546. doi: 10.3389/fpsyg.2021.690546. eCollection 2021.
Cicek Gumus E, Oncel S
Validity and Reliability of The Chedoke-McMaster Attitudes Towards Children with Handicaps Scale in Turkey: A Methodological Study. Florence Nightingale J Nurs. 2020 Mar 6;28(1):1-12. doi: 10.5152/FNJN.2020.426719. eCollection 2020 Feb.

The Effect of Awareness Training Programme on School Age Children's Attitudes Towards Children With Special Needs: A Mixed Method Research

Clinical trial NCT06163521 - References